Abstract
Despite great advances in our understanding of the molecular causes of liver cancer, significant gaps still remain in our knowledge of the disease pathogenesis and development of effective strategies for early diagnosis and treatment. The present study was conducted to evaluate the chemopreventive activity of ellagic acid (EA) against experimental liver cancer in rats. This is the first report that implies a possible role of EA in controlling liver cancer through activation of mitochondrial outer membrane permeability via activating proteins such as Bax, bcl-2, cyt-C, and caspase-9, which play important roles in apoptosis. Downregulation of NF-κB, cyclin D1, cyclin E1, matrix metalloproteinases (MMP)-2, MMP-9, and proliferating cell nuclear antigen (PCNA) were noted in EA-treated experimental rats and controlled inflammation mediated liver cancer when compared to the diethylnitrosamine (DEN)-induced group. Transmission electron microscopy (TEM) analysis of the livers of experimental rats demonstrated that EA treatment renovated its internal architecture. Overall, these results demonstrate the value of molecular approaches in identifying the potential role of EA as an effective chemopreventive agent.
Similar content being viewed by others
References
Zhao, J. L., Zhao, J., & Jiao, H. J. (2013). Applied Biochemistry and Biotechnology, 172, 784–791.
Khan, M. S., Halagowder, D., & Niranjali, S. D. (2011). Food and Chemical Toxicology, 49, 173–178.
Ford, N. A., Lashinger, L. M., Allott, E. H., & Hursting, S. D. (2013). Frontiers Oncology, 3, 209.
Jakszyn, P. G., Allen, N. E., Barroso, L. L., et al. (2012). Cancer Epidemiology Biomarkers, 21, 547–551.
Mittal, G., Brar, A. P., & Soni, G. (2006). Pharmacological Reports, 58, 413–419.
Mittal, G., Brar, A. P., & Soni, G. (2006). Pharmacological Reports, 58, 413–419.
Sivaramakrishnan, V., & Devaraj, S. N. (2009). Chemico-Biological Interactions, 180, 353–359.
Al-Kaseem, M., Al-Assaf, Z., & Karabet, F. (2013). Pharmacology and Pharmacy, 4, 611–618.
Lee, L., Wang, K., Li, G., Xie, Z., Wang, Y., Xu, J., et al. (2011). BMC Genomics, 12(S3), 1–13.
Kim, J. Y., Ok, E., Kim, Y. J., Choi, K. S., & Kwon, O. (2013). Nutrition Research and Practice, 7(3), 153–159.
Umesalma, S., & Sudhandiran, G. (2010). Basic and Clinical Pharmacology and Toxicology, 107, 650–655.
Jiang, W., Zhu, Z., McGinley, J. N., Bayoumy, K. E., Manni, A., & Thompson, H. J. (2013). Cancer Research, 72(15), 3795–806.
Vanella, L., Giacomo, C. D., Acquaviva, R., Barbagallo, I., Volti, G. L., Cardile, V., et al. (2013). Cancers, 5, 726–738.
Pittoni, P., & Colombo, M. P. (2012). Cancer Research, 72, 831–835.
Choi, Y. J., Li, X., Hydbring, P., Sanda, T., Stefano, J., Christie, A. L., et al. (2012). Cancer Cell, 22(4), 438–451.
Herszényi, L., Hritz, I., Lakatos, G., Varga, M. Z., & Tulassay, Z. (2012). International Journal of Molecular Sciences, 13, 13240–13263.
Srigopalram, S., Ilavenil, S., & Indira, A. J. (2012). Biomedicine and Preventive Nutrition, 2, 1–8.
Nelson, L. J., Treskes, P., Howie, A. F., Walker, S. W., Hayes, P. C., & Plevris, J. N. (2013). Scientific Reports, 3, 2735.
Ranieri, G., Labriola, A., Achille, G., Florio, G., Zito, A. F., & Grammatica, L. (2002). International Journal of Oncology, 21(6), 1317–1323.
Ramakrishnan, G., Elinos-Baaez, C. M., Jagan, S., Augustine, T. A., Kamaraj, S., Anandakumar, P., et al. (2008). Molecular and Cellular Biochemistry, 313(1–2), 53–61.
Ramakrishnan, G., Jagan, S., Kamaraj, S., Anandakumar, P., & Devaki, T. (2009). Investigational New Drugs, 27, 233–240.
Hassoun, E. A., & Cearfoss, J. (2011). Toxicological and Environmental Chemistry, 93(2), 332–344.
Gounaris, E., Erdman, S. E., Restaino, C., Gurish, M. F., Friend, D. S., & Gounari, F. (2007). Proceedings of the National Academy of Sciences of the United States of America, 104(50), 19977–19982.
Grizzi, F., Di Caro, G., Laghi, L., Hermonat, P., Mazzola, P., Nquyen, D. D., et al. (2013). Immunity & Ageing, 10(1), 1–10.
Hodges, K., Kennedy, L., Meng, F., Alpini, G., & Francis, H. (2012). Translation of Gastrointestinal Cancer, 1(2), 138–150.
Kang, J. S., Kang, H. G., Park, Y. I., Lee, H., Park, K., Lee, Y. S., et al. (2013). Experimental and Therapeutic Medicine, 5, 138–142.
Sun, H., Yu, L., Wei, H., & Liu, G. (2012). Journal of Biomedicine & Biotechnology, 2012(584728), 1–9.
Qasim, B. J., Ali, H. H., & Hussein, A. G. (2012). Saudi Journal of Gastroenterology, 18, 268–76.
Zhao, H., Ho, P. C., Lo, Y. H., Espejo, A., Bedford, M. T., Hung, M. C., et al. (2012). PloS One, 7(e29416), 1–7.
Muriel, P. (2009). NF-kB in liver diseases: a target for drug therapy. Journal of Applied Toxicology, 29, 91–100.
Holdenrieder, S., & Stieber, P. (2004). Clinical Biochemistry, 37, 605–617.
Rusca, N., Dehò, L., Montagner, S., Zielinski, C. E., Sica, A., Sallusto, F., et al. (2012). Molecular and Cellular Biology, 32, 4432–4444.
Boström, P., Söderström, M., Palokangas, T., Vahlberg, T., Collan, Y., Carpen, O., et al. (2009). BMC Research Notes, 2(140), 1–8.
Thieringer, F. R., Maass, T., Anthon, B., Meyer, E., Schirmacher, P., Longerich, T., et al. (2012). Molecular Carcinogenesis, 51, 439–448.
Chantrian, C. F., Henriet, P., Jodele, S., Emonard, H., Feron, O., & Courtoy, P. J. (2006). European Journal of Cancer, 42(3), 310–318.
Huang, X. H., Chen, J. S., Wang, Q., Chen, X. L., Wen, L., Chen, L. Z., et al. (2011). The Journal of Pathology, 225(3), 463–472.
Partyka, R., Gonciarz, M., Jałowiecki, P., Kokocińska, D., & Byrczek, T. (2012). Medical Science Monitor, 18(4), 130–134.
Lo, S. J., Fan, L. C., Tsai, Y. F., Lin, K. Y., Huang, H. L., Wang, T. H., et al. (2013). Hepatology, 57(5), 1893–1905.
Yu, J. Q., Bao, W., & Lei, J. C. (2013). Phytotherapy Research, 27, 251–257.
Zhang, C. Z., Pan, Y., Cao, Y., Lai, P. B. S., Liu, L., Chen, G. G., & Yun (2012). Journal of PLoS ONE, 7(6), e39870, 1–10.
Mahdavi, M., Davoodi, J., Zali, M. R., & Foroumadi, A. (2011). Biomedicine & Pharmacotherapy, 65, 175–182.
Wang, N., Feng, Y., Zhu, M., Tsang, C. M., Man, K., Tong, Y., et al. (2010). Berberine Induces Autophagic Cell Death and Mitochondrial Apoptosis in Liver Cancer Cells: The Cellular Mechanism. Journal of Cellular Biochemistry, 111, 1426–1436.
Kang, J. H., Zhang, W. Q., Song, W., Shen, D. Y., Li, S. S., Tian, L., et al. (2012). Applied Biochemistry and Biotechnology, 166(4), 942–51.
Acknowledgments
This research was supported by Golden Seed Project (Center for Horticultural Seed Development, No. 213003-04-1-CG100), Ministry of Agriculture, Food and Rural Affairs (MAFRA), Ministry of Oceans and Fisheries (MOF), Rural Development Administration (RDA), and Korea Forest Service (KFS).
Conflict of Interest
The authors confirm that there is no conflict of interest associated with this work.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Srigopalram, S., Jayraaj, I.A., Kaleeswaran, B. et al. Ellagic Acid Normalizes Mitochondrial Outer Membrane Permeabilization and Attenuates Inflammation-Mediated Cell Proliferation in Experimental Liver Cancer. Appl Biochem Biotechnol 173, 2254–2266 (2014). https://doi.org/10.1007/s12010-014-1031-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12010-014-1031-y